BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36510984)

  • 1. Promoter methylation status of key genes and its implications in the pathogenesis of endometriosis, endometrioid carcinoma of ovary and endometrioid endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Sharma A
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S328-S334. PubMed ID: 36510984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
    J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of the GSTM1 promoter is associated with ovarian endometriosis.
    Zhao J; Wang L; Li Y; Zhao W; Kang S
    Hum Reprod; 2019 May; 34(5):804-812. PubMed ID: 30989213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
    Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
    Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Bhardwaj P
    Indian J Med Res; 2022 Sep; 156(3):516-523. PubMed ID: 36751747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
    Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
    Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.
    Chan QK; Khoo US; Chan KY; Ngan HY; Li SS; Chiu PM; Man LS; Ip PP; Xue WC; Cheung AN
    J Mol Diagn; 2005 Feb; 7(1):8-16. PubMed ID: 15681469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study.
    Ishizaka A; Taguchi A; Tsuruga T; Maruyama M; Kawata A; Miyamoto Y; Tanikawa M; Ikemura M; Sone K; Mori M; Koga K; Ushiku T; Oda K; Osuga Y
    BMC Womens Health; 2022 Aug; 22(1):332. PubMed ID: 35932070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.
    Körner M; Burckhardt E; Mazzucchelli L
    Mod Pathol; 2006 Dec; 19(12):1615-23. PubMed ID: 16980942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic changes in the eutopic endometrium of women with endometriosis: association with decreased endometrial αvβ3 integrin expression.
    Joshi NR; Kohan-Ghadr HR; Roqueiro DS; Yoo JY; Fru K; Hestermann E; Yuan L; Ho SM; Jeong JW; Young SL; Lessey BA; Fazleabas AT
    Mol Hum Reprod; 2021 May; 27(6):. PubMed ID: 33693877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of miR-203 in endometrial carcinomas.
    Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
    Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis.
    Zidan HE; Rezk NA; Alnemr AA; Abd El Ghany AM
    J Reprod Immunol; 2015 Nov; 112():63-7. PubMed ID: 26276091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
    Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
    Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of MGMT promoter methylation in endometrial cancer.
    Rimel BJ; Huettner P; Powell MA; Mutch DG; Goodfellow PJ
    Gynecol Oncol; 2009 Jan; 112(1):224-8. PubMed ID: 18973931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.